Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000961491 | SCV001108538 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505446 | SCV002805109 | likely benign | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2021-07-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000961491 | SCV003799985 | likely benign | not provided | 2022-05-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000961491 | SCV005041709 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SLC4A1: BP4, BP7, BS1, BS2 |
Prevention |
RCV004553444 | SCV004765115 | benign | SLC4A1-related disorder | 2020-01-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |